-+ 0.00%
-+ 0.00%
-+ 0.00%

Trinity Biotech says clinical trial data show CGM+ detects nocturnal false low glucose readings

PUBT·07/02/2026 12:31:55
Listen to the news
Trinity Biotech says clinical trial data show CGM+ detects nocturnal false low glucose readings
  • Trinity Biotech released pre-pivotal clinical trial results for its CGM+ wearable, based on about 5,000 hours of wear data.
  • Data supports an algorithm that flags nocturnal compression-related false low glucose readings, a common source of inaccurate CGM alarms.
  • Management positioned the capability as a differentiator as CGM+ moves toward a pivotal trial and regulatory submission.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020830PRIMZONEFULLFEED9756151) on July 02, 2026, and is solely responsible for the information contained therein.